Cindy Bowen
Critical Care Medicine · Bethesda, MDNPI 1669646121
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $920 and has fallen 98.7% since, to $12 in 2021.
Across 76 payments — averaging $15.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$222
- GSK$199
- Philips North America LLC$131
- Sunovion Pharmaceuticals Inc.$130
- Novartis$111
- Boehringer Ingelheim$74
- plus $275 from 10 others
What the payments were for
- Food & beverage$1,13099%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 14 | $222 |
| GSK | 16 | $199 |
| Philips North America LLC | 7 | $131 |
| Sunovion Pharmaceuticals Inc. | 12 | $130 |
| Novartis | 6 | $111 |
| Boehringer Ingelheim | 4 | $74 |
| Genentech USA, Inc. | 4 | $71 |
| Advanced Respiratory, Inc | 2 | $34 |
| Optinose US, Inc. | 2 | $33 |
| Mylan Specialty L.p. | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Insmed, Inc. | 1 | $14 |
| Mallinckrodt Enterprises LLC | 1 | $12 |
How this compares
$1,142 in reported general payments places this provider in the 75th percentile of 231 critical care medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Bethesda
- Robert BrowningBethesda$73K
- Lydia Gilbert-McclainBethesda$68K
- Daniel BrodieBethesda$26K
- Mark GladwinBethesda$3K
- Christopher LettieriBethesda$3K
- Amirali NaderBethesda$1K
- Leo RotelloBethesda$726
- Christopher ChapmanMitchellville$248K
- David Feller KopmanBaltimore$236K
- Elizabeth HuntBaltimore$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.